title: Gefitinib for refractory advanced non-small-cell lung cancer.
authors.forename: Hisashi
authors.initials: H
authors.lastname: Moriguchi
authors.forename: Tae-You
authors.initials: TY
authors.lastname: Kim
authors.forename: Chifumi
authors.initials: C
authors.lastname: Sato
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000235:genetics; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011799:Quinazolines / Q000627:therapeutic use*; D012907:Smoking / Q000009:adverse effects*; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib